EVAXION

Welcome to the Brand page for “EVAXION”, which is offered here for Software; software based on artificial intelligence; artificial intelligence and machine learning software; platforms for artificial intelligence; software for the treatment of cancer; software for design and development of immunotherapy; software and software based on artificial intelligence for identification of antigens and epitopes; software and software based on artificial intelligence for design and development of vaccines and medicines; software and software based on artificial intelligence for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites;pharmaceuticals and medical preparations; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites; biopharmaceuticals for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites; preparations for immunotherapy; antibodies; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use;scientific and technological research and services; research and development services in the field of immunology and oncology, decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; basic and clinical research in the field of science and medicine; research and development of vaccines and medicines; scientific and technological research relating to virus, oncology, and autoimmune diseases, scientific and technological research relating to allergies; blood processing, the blood process of patients' blood to isolate lymphocytes for the use in immunotherapy for therapeutic medical research;.

Its status is currently believed to be active. Its class is unavailable. “EVAXION” is believed to be currently owned by “EVAXION BIOTECH A/S”.